Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (73)Elecoglipron an oral small molecule GLP-1 RA moves to Phase III programme
Preheader (150)Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portf
Typography
Arial
Colors
Text Analysis
Body Words209
Subject Words12
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px914 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

Elecoglipron an oral small molecule GLP-1 RA moves to Phase III programme

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portf
Elecoglipron an oral small molecule GLP-1 RA moves to Phase III programme